← Evidence map

GuidelineClinical pharmacology and therapeutics2024

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.

Julio D Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38951961